Sep 15, 2025, 08:42
W. Alberto Sifuentes Giraldo Highlights 4-Fold Higher Preeclampsia Risk in Pregnant SLE Patients with LN and APS
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), has shared a post on LinkedIn:
“Pregnant women with systemic lupus erythematosus (SLE) face a substantially higher risk of preeclampsia (PE) and PE with severity criteria, with both lupus nephritis (LN) and antiphospholipid syndrome (APS) emerging as strong, independent risk factors for these complications, as confirmed by a Spanish nation-wide cohort study:
- LN and APS nearly double PE risk beyond SLE by itself. Both conditions potentiate each other, since the combination of LN and APS results in a 4-fold higher risk of PE compared with SLE women without any of them.
- Renal involvement in SLE confers a high likelihood of developing PE, particularly in the more severe forms; LN independently triples PE with severity criteria odds.
These findings indicate that LN, and APS should be a fundamental factor in pre-conceptional planning, PE risk stratification, pregnancy monitoring, and prognostic assessment of PE in SLE patients.”

More insights on Hemostasis Today.
-
Sep 14, 2026, 09:44Mohammad Salar Amoli: Thrombin The Master Regulator of Coagulation
-
Sep 14, 2026, 09:23Claire Harrison: HemaSphere Introduces New Patient Editor Role
-
Sep 14, 2026, 09:13Eirini Zorba: Plasmapheresis in Focus Understanding Its Role in Patient Care
-
Sep 14, 2026, 08:55Abdulrahman Al-Mashdali։ Immune Checkpoint Inhibitor Associated HLH
-
Sep 14, 2026, 07:54Islam Sadek: SOHO2026 Highlights Advances in Hematologic Malignancies
-
Sep 14, 2026, 07:45Flora Peyvandi: Building a More Equitable Future for Hemophilia Care
-
Sep 14, 2026, 07:37Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
-
Sep 14, 2026, 07:29Eric Topol – Will AI Replace Clinicians?
-
Sep 14, 2026, 07:19Ruhi Mehra: The Evolving Science of Stem Cell Enumeration